Oncolytic Virus Therapy Market: Size, Trends, and Growth Opportunities

The oncolytic virus therapy market is rapidly evolving as a forefront innovation within biopharmaceutical oncology, harnessing genetically modified viruses to selectively target and destroy cancer cells. Significant advances in clinical outcomes and technological development underscore its expanding market scope and dynamic business growth potential.

Oncolytic Virus Therapy Market is estimated to be valued at USD 17.8 Mn in 2025 and is expected to reach USD 87.3 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 25.5% from 2025 to 2032.
Oncolytic Virus Therapy Market Growth is propelled by increasing adoption in immuno-oncology coupled with advancements in viral vector engineering. Recent market analysis reveals expanding market segments in melanoma, glioblastoma, and solid tumors, signifying the broadening market scope and evolving market dynamics. This market report highlights how emerging market trends including personalized viral therapies influence market growth and investment appetites.

Oncolytic Virus Therapy Market-https://www.coherentmarket...